Stereotactic brain procedures for Parkinson's (NCT00575081)

Improve targeting for brain stimulation

Trial ID
NCT00575081
Official Title
Physiological Brain Atlas Development
Goal
Improve targeting for brain stimulation
Status
RECRUITING
Sponsor
Vanderbilt University Medical Center
Study Type
OBSERVATIONAL
Enrollment
5000 participants
Conditions
Parkinson's Disease, Obsessive Compulsive Disorder, Dystonia, Essential Tremor, Epilepsy
Interventions
Stereotactic brain procedures

Summary For Families

The goal is to build a detailed physiological atlas of brain signals to help surgeons find the exact spots for stereotactic procedures like deep brain stimulation, lesioning, or electrode placement in Parkinson's and related movement and seizure disorders. During the stereotactic procedures the team records electrical and other physiological signals from targeted brain areas, mapping those signals to anatomy so future treatments can be targeted more precisely; no new drug or experimental treatment is given, the study collects data during procedures you would already be having. The study is open to people aged 6 to 90 who have been recommended for and consent to a stereotactic brain procedure, and it excludes anyone not recommended or not able to give informed consent.

Locations

  • Vanderbilt Univeristy, Nashville, Tennessee, United States

Frequently Asked Questions

What is this trial testing?
This trial is studying Stereotactic brain procedures. The goal is to build a detailed physiological atlas of brain signals to help surgeons find the exact spots for stereotactic procedures like deep brain stimulation, lesioning, or electrode placement in Parkinson's and related movement and seizure disorders. During the stereotactic procedures the team records electrical and other physiological signals from targeted brain areas, mapping those signals to anatomy so future treatments can be targeted more precisely; no new drug or experimental treatment is given, the study collects data during procedures you would already be having. The study is open to people aged 6 to 90 who have been recommended for and consent to a stereotactic brain procedure, and it excludes anyone not recommended or not able to give informed consent.
Who can participate?
Participants must be between 6 Years and 90 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 20 years.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
What procedures are involved in this trial?
Based on the protocol, this trial involves: Brain surgery / implanted device (invasive); Surgical procedure (invasive); MRI scan (non-invasive). Confirm the full schedule with the study coordinator.

Related Reading

View on ClinicalTrials.gov